TABLE 8.
Predictors of mortality
| Risk factor | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| P value | OR | 95% CI | P value | OR | 95% CI | |
| Age | <.001 | 10 | 9.0‐13.0 | <.001 | 1.03 | 1.02‐1.04 |
| Male gender | .014 | 1.40 | 1.07‐1.88 | |||
| Coronary artery disease | <.001 | 2.00 | 1.50‐2.90 | |||
| Heart failure | <.001 | 2.40 | 1.60‐3.56 | |||
| Chronic kidney disease | <.001 | 2.90 | 1.98‐4.30 | |||
| Diabetes mellitus | .012 | 1.40 | 1.08‐1.89 | |||
| Hypertension | .002 | 1.55 | 1.18‐2.04 | |||
| Hydroxychloroquine | .003 | 1.57 | 1.17‐2.10 | |||
| Lopinavir/ritonavir | .008 | 0.65 | 0.47‐0.89 | |||
| Azithromycin coadministration | <.001 | 2.33 | 1.70‐3.20 | <.001 | 2.23 | 1.60‐3.10 |
| Furosemide | <.001 | 5.09 | 3.75‐6.90 | <.001 | 2.60 | 1.84‐3.65 |
| Amiodarone | <.001 | 4.65 | 2.37‐9.15 | .033 | 2.37 | 1.07‐5.27 |
| Beta‐blocker | <.001 | 2.46 | 1.86‐3.25 | |||
| Digoxin | <.001 | 4.88 | 2.64‐9.05 | |||
| Hypokalaemia | .002 | 1.60 | 1.18‐2.20 | |||
| On‐treatment QTc ≥ 500 ms | <.001 | 2.84 | 2.03‐3.97 | |||
| ∆QT ≥ 60 ms | <.001 | 2.40 | 1.78‐3.24 | |||
| Acute renal dysfunction | <.001 | 5.70 | 4.30‐7.58 | <.001 | 3.70 | 2.73‐5.02 |
| Acute hepatic dysfunction | <.001 | 1.77 | 1.27‐2.45 | |||
Abbreviations: CI, confidence interval; OR, odds ratio.